Key facts
- This page summarizes Dan Zabrowski's Form 3 filing for ACTUATE THERAPEUTICS, INC. (ACTU).
- 0 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 12 Aug 2024, 21:49.
Dan Zabrowski - 12 Aug 2024 Form 3 Insider Report for ACTUATE THERAPEUTICS, INC. (ACTU)
- Reporting relationship
- Director
- Issuer ticker
- ACTU
- Reported as of
- 12 Aug 2024
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 12 Aug 2024, 21:49:17 UTC
- Prior SEC filing
- 25 Aug 2023
- Next SEC filing
- 23 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Paul Lytle, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Dan Zabrowski filed Form 3 for ACTUATE THERAPEUTICS, INC. (ACTU) on 12 Aug 2024.
Change
- Previous filing in this sequence was filed on 25 Aug 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ACTU
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 76,348
- Date
- 12 Aug 2024
- Ownership
- By Catharine A. Zabrowski Irrevocable Trust
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ACTU
holding
Derivative
Non-Qualified Stock Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 12 Aug 2024
- Ownership
- By Catharine A. Zabrowski Irrevocable Trust
- Underlying class
- Common Stock
- Underlying amount
- 15,942
- Exercise price
- $2.14
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents shares held by the Catharine A. Zabrowski Irrevocable Trust, of which Catherine A. Zabrowski, the wife of the reporting person, is the trustee and has sole voting and investment power over such shares and options. The reporting person may be deemed to have or share such investment and/or voting power due to the trustee's status as his spouse. The reporting person disclaims beneficial ownership of such shares other than to the extent he may have a pecuniary interest therein.
Footnote F2
15,942 stock options, which are held by the Catharine A. Zabrowski Irrevocable Trust, that are exercisable for shares of common stock of the issuer were fully vested as of April 30, 2024.
SEC remarks
Exhibit List Exhibit 24 - Power of Attorney